Preview

Rational Pharmacotherapy in Cardiology

Advanced search
Fullscreen

For citation:


RIVAROXABAN HAS DEMONSTRATED AN ADVANTAGE OVER ACETYLSALICYLIC ACID IN PREVENTING THE RECURRENCE OF VENOUS THROMBOEMBOLIC EVENTS IN THE EINSTEIN CHOICE STUDY. Rational Pharmacotherapy in Cardiology. 2017;13(2):284. (In Russ.)

Views: 117


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)